Accolade 주식 주식분석 | 주식가격 | 뉴스 | ACCD | US00437E1029 | A2P7Z2

날짜	Accolade 주식 가격
	4.03 undefined
	4.21 undefined
	4.16 undefined
	4.24 undefined
	4.34 undefined
	4.31 undefined
	4.22 undefined
	4.33 undefined
	4.41 undefined
	4.42 undefined
	4.20 undefined
	4.33 undefined
	4.18 undefined
	4.27 undefined
	4.13 undefined
	4.15 undefined
	4.00 undefined
	4.06 undefined
	3.89 undefined

날짜	Accolade 매출	Accolade EBIT	Accolade 이익
2030e	1.2 조. undefined	0 undefined	0 undefined
2029e	1.02 조. undefined	-102,000 undefined	0 undefined
2028e	852.36 백만 undefined	-27.13 백만 undefined	37.8 백만 undefined
2027e	616.21 백만 undefined	-71.62 백만 undefined	-62.32 백만 undefined
2026e	540.46 백만 undefined	-81.76 백만 undefined	-76.13 백만 undefined
2025e	476.27 백만 undefined	-92.77 백만 undefined	-87.39 백만 undefined
2024	414.29 백만 undefined	-113.6 백만 undefined	-99.81 백만 undefined
2023	363.1 백만 undefined	-162.6 백만 undefined	-459.7 백만 undefined
2022	310 백만 undefined	-112.5 백만 undefined	-123.1 백만 undefined
2021	170.4 백만 undefined	-46.8 백만 undefined	-50.7 백만 undefined
2020	132.5 백만 undefined	-48.2 백만 undefined	-51.4 백만 undefined
2019	94.8 백만 undefined	-54 백만 undefined	-56.5 백만 undefined
2018	76.8 백만 undefined	-59.5 백만 undefined	-61.3 백만 undefined

	매출	EBIT	이익
2018	76.8 백만 USD	-59.5 백만 USD	-61.3 백만 USD
2019	94.8 백만 USD	-54 백만 USD	-56.5 백만 USD
2020	132.5 백만 USD	-48.2 백만 USD	-51.4 백만 USD
2021	170.4 백만 USD	-46.8 백만 USD	-50.7 백만 USD
2022	310 백만 USD	-112.5 백만 USD	-123.1 백만 USD
2023	363.1 백만 USD	-162.6 백만 USD	-459.7 백만 USD
2024	414.29 백만 USD	-113.6 백만 USD	-99.81 백만 USD
2025e	476.27 백만 USD	-92.77 백만 USD	-87.39 백만 USD
2026e	540.46 백만 USD	-81.76 백만 USD	-76.13 백만 USD
2027e	616.21 백만 USD	-71.62 백만 USD	-62.32 백만 USD
2028e	852.36 백만 USD	-27.13 백만 USD	37.8 백만 USD
2029e	1.02 조. USD	-102,000 USD	0 USD
2030e	1.2 조. USD	0 USD	0 USD

2018	2019	2020	2021	2022	2023	2024	2025e	2026e	2027e	2028e	2029e	2030e
0.08	0.09	0.13	0.17	0.31	0.36	0.41	0.48	0.54	0.62	0.85	1.02	1.2
-	23.68	40.43	28.79	82.35	17.10	14.05	14.98	13.45	14.07	38.31	19.84	17.73
30.26	36.17	43.94	44.71	45.48	45.18	46.38	-	-	-	-	-	-
23	34	58	76	141	164	192	0	0	0	0	0	0
-59	-54	-48	-46	-112	-162	-113	-92	-81	-71	-27	0	0
-77.63	-57.45	-36.36	-27.06	-36.13	-44.63	-27.29	-19.33	-15.00	-11.53	-3.17	-	-
-61	-56	-51	-50	-123	-459	-99	-87	-76	-62	37	0	0
-	-8.20	-8.93	-1.96	146.00	273.17	-78.43	-12.12	-12.64	-18.42	-159.68	-	-
47	47	47	29.4	63.8	71.3	74.91	0	0	0	0	0	0
-	-	-	-	-	-	-	-	-	-	-	-	-

2018	2019	2020	2021	2022	2023

13.5	42.7	33.2	433.9	365.9	321.1
7	0.4	1.2	11.8	30.8	26.7
0	0	0	0	0	0
0	0	0	0	0	0
2.9	3.7	14.5	8.3	12.5	18.1
23.4	46.8	48.9	454	409.2	365.9
21.5	15.3	13.6	9.2	44.9	44.3
0	0	0	0	0	0
0	0	0	0	0	0
0	0	2.1	0.6	244.7	203.2
0	0	4	4	577.9	278.2
2.2	3.6	4.6	7.7	8.9	11.4
23.7	18.9	24.3	21.5	876.4	537.1
0.05	0.07	0.07	0.48	1.29	0.9

167	214.7	233	0	0	0
0.03	0.04	0.06	0.76	1.35	1.43
-213	-269.5	-320.9	-371.5	-494.6	-954.3
0	0	0	0	0	0
0	0	0	0	0	0
-16.7	-15.9	-23.8	390.9	855.8	473.8
1.6	2.5	5.3	7.4	7.8	10.2
19.6	22.8	30.4	40.2	47.4	50.9
15.3	31.5	34.3	31.5	55.9	57.8
0	0	0	0	0	0
5	0	0	0	0.6	0.6
41.5	56.8	70	79.1	111.7	119.5
15.9	19.2	21.1	0	280.7	282.3
0	0	0	0	0	0
6.4	5.9	5.9	5.6	37.3	27.5
22.3	25.1	27	5.6	318	309.8
63.8	81.9	97	84.7	429.7	429.3
0.05	0.07	0.07	0.48	1.29	0.9

2018	2019	2020	2021	2022	2023
-61	-56	-51	-50	-123	-459
7	9	8	8	42	46
0	0	0	0	-6	-4
4	25	-5	3	-7	-1
18	10	20	23	105	450
1	2	2	2	0	1
0	0	0	0	0	0
-38	-16	-34	-25	-62	-40
-7	-3	-3	-2	-3	-7
-7	-3	-3	-2	-263	-7
0	0	0	0	-260	0
0	0	0	0	0	0
14	-2	1	-22	287	0
0	50	26	451	13	4
15	48	28	428	257	3
-	-	-	-	-42.00	-1.00
0	0	0	0	0	0
-30	29	-9	400	-68	-44
-45.44	-19.67	-37.57	-27.6	-65.97	-47.94
0	0	0	0	0	0

Accolade 브루토마진	Accolade 이익 마진	Accolade EBIT-마진	Accolade 이익 마진
2030e	46.52 %	0 %	0 %
2029e	46.52 %	-0.01 %	0 %
2028e	46.52 %	-3.18 %	4.43 %
2027e	46.52 %	-11.62 %	-10.11 %
2026e	46.52 %	-15.13 %	-14.09 %
2025e	46.52 %	-19.48 %	-18.35 %
2024	46.52 %	-27.42 %	-24.09 %
2023	45.22 %	-44.78 %	-126.6 %
2022	45.48 %	-36.29 %	-39.71 %
2021	45.01 %	-27.46 %	-29.75 %
2020	44.38 %	-36.38 %	-38.79 %
2019	36.08 %	-56.96 %	-59.6 %
2018	30.47 %	-77.47 %	-79.82 %

	브루토마진	EBIT-마진	이익 마진
2018	30.47 %	-77.47 %	-79.82 %
2019	36.08 %	-56.96 %	-59.6 %
2020	44.38 %	-36.38 %	-38.79 %
2021	45.01 %	-27.46 %	-29.75 %
2022	45.48 %	-36.29 %	-39.71 %
2023	45.22 %	-44.78 %	-126.6 %
2024	46.52 %	-27.42 %	-24.09 %
2025e	46.52 %	-19.48 %	-18.35 %
2026e	46.52 %	-15.13 %	-14.09 %
2027e	46.52 %	-11.62 %	-10.11 %
2028e	46.52 %	-3.18 %	4.43 %
2029e	46.52 %	-0.01 %	0 %
2030e	46.52 %	0 %	0 %

날짜	Accolade 주당 매출	Accolade EBIT 당 주식	Accolade 주당 이익
2030e	15.25 undefined	0 undefined	0 undefined
2029e	12.95 undefined	0 undefined	0 undefined
2028e	10.81 undefined	0 undefined	0.48 undefined
2027e	7.82 undefined	0 undefined	-0.79 undefined
2026e	6.86 undefined	0 undefined	-0.97 undefined
2025e	6.04 undefined	0 undefined	-1.11 undefined
2024	5.53 undefined	-1.52 undefined	-1.33 undefined
2023	5.09 undefined	-2.28 undefined	-6.45 undefined
2022	4.86 undefined	-1.76 undefined	-1.93 undefined
2021	5.8 undefined	-1.59 undefined	-1.72 undefined
2020	2.82 undefined	-1.03 undefined	-1.09 undefined
2019	2.02 undefined	-1.15 undefined	-1.2 undefined
2018	1.63 undefined	-1.27 undefined	-1.3 undefined

	주당 매출	EBIT 당 주식	주당 이익
2018	1.63 USD	-1.27 USD	-1.3 USD
2019	2.02 USD	-1.15 USD	-1.2 USD
2020	2.82 USD	-1.03 USD	-1.09 USD
2021	5.8 USD	-1.59 USD	-1.72 USD
2022	4.86 USD	-1.76 USD	-1.93 USD
2023	5.09 USD	-2.28 USD	-6.45 USD
2024	5.53 USD	-1.52 USD	-1.33 USD
2025e	6.04 USD	0 USD	-1.11 USD
2026e	6.86 USD	0 USD	-0.97 USD
2027e	7.82 USD	0 USD	-0.79 USD
2028e	10.81 USD	0 USD	0.48 USD
2029e	12.95 USD	0 USD	0 USD
2030e	15.25 USD	0 USD	0 USD

	주식 수량
2018	47 백만 Aktien
2019	47 백만 Aktien
2020	47 백만 Aktien
2021	29.4 백만 Aktien
2022	63.8 백만 Aktien
2023	71.3 백만 Aktien
2024	74.91 백만 Aktien
2025e	74.91 백만 Aktien
2026e	74.91 백만 Aktien
2027e	74.91 백만 Aktien
2028e	74.91 백만 Aktien
2029e	74.91 백만 Aktien
2030e	74.91 백만 Aktien

EPS-예상치	EPS-실제	보고 분기
-0.49	-0.35 (28.86 %)	2025 Q1
-0.07	-0.1 (-38.5 %)	2024 Q4
-0.45	-0.28 (37.92 %)	2024 Q3
-0.55	-0.43 (21.42 %)	2024 Q2
-0.63	-0.52 (17.76 %)	2024 Q1
-0.43	-0.42 (2.67 %)	2023 Q4
-0.63	-0.56 (11.24 %)	2023 Q3
-0.74	-0.66 (10.67 %)	2023 Q2
-0.68	-0.62 (9.42 %)	2023 Q1
-0.36	-0.51 (-40.23 %)	2022 Q4
-0.66	0.31 (146.76 %)	2022 Q3
-0.57	-0.97 (-69.11 %)	2022 Q2
-0.37	-0.66 (-76.33 %)	2022 Q1
-0.1	-0.22 (-117.39 %)	2021 Q4
-0.36	-0.32 (9.99 %)	2021 Q3
-0.41	-0.47 (-14.13 %)	2021 Q2
-0.41	-1.69 (-314.22 %)	2021 Q1

%-지분	이름	주식	변경
7.56288 %	Brown Advisory	5,962,571	-103,518
7.11954 %	ARK Investment Management LLC	5,613,043	-1,192,165
6.84768 %	Andreessen Horowitz	5,398,708	0
6.84768 %	Ah Capital Management LLC (Sibling)	5,398,708	5,398,708
6.74121 %	The Vanguard Group, Inc.	5,314,773	42,354
6.20565 %	BlackRock Institutional Trust Company, N.A.	4,892,535	288,364
5.71715 %	Bellevue Asset Management AG	4,507,404	-20,519
4.55745 %	JP Morgan Asset Management	3,593,096	-16,910
4.42035 %	Rock Springs Capital Management LP	3,485,000	572,000
3.30029 %	JPMorgan Asset Management U.K. Limited	2,601,945	-49,745
2.43744 %	Dimensional Fund Advisors, L.P.	1,921,676	50,311
2.15317 %	Nikko Asset Management Co., Ltd.	1,697,560	-104,934
1.98940 %	State Street Global Advisors (US)	1,568,442	48,128
1.94816 %	Geode Capital Management, L.L.C.	1,535,926	84,985
1.77439 %	Singh (Rajeev)	1,398,928	1,561
1.49326 %	Fairman Group, LLC	1,177,287	1,177,287
1.41386 %	IEQ Capital LLC	1,114,691	1,114,691
1.17955 %	Balyasny Asset Management LP	929,956	400,529
1.10680 %	Nuveen LLC	872,604	-3,954
0.95256 %	Apo Asset Management GmbH	751,000	0
0.86868 %	Nikko Asset Management Americas, Inc.	684,865	314,425
0.86002 %	Principal Global Investors (Equity)	678,036	116
0.76388 %	Northern Trust Investments, Inc.	602,244	29,500
0.73302 %	Morgan Stanley & Co. LLC	577,910	221,908
0.71938 %	Point72 Asset Management, L.P.	567,163	567,163
0.71500 %	Jane Street Capital, L.L.C.	563,708	316,800
0.70520 %	Charles Schwab Investment Management, Inc.	555,982	34,559
0.61454 %	Renaissance Technologies LLC	484,500	48,500
0.59741 %	JFG Wealth Management, LLC	471,000	471,000
0.54637 %	BlackRock Financial Management, Inc.	430,756	30,496
0.45359 %	Cross Creek Advisors, LLC	357,607	0
0.43362 %	Hilton (Michael W.)	341,867	514
0.41151 %	D. E. Shaw & Co., L.P.	324,434	-506,009
0.40692 %	BofA Global Research (US)	320,819	16,601
0.31085 %	Millennium Management LLC	245,078	85,347
0.30834 %	Columbia Threadneedle Investments (US)	243,097	68,986
0.30547 %	Woodline Partners LP	240,829	-934,963
0.27780 %	Conestoga Capital Advisors, LLC	219,019	-5,617
0.26813 %	JPMorgan Private Bank (United States)	211,396	61,699
0.26592 %	PGIM Quantitative Solutions LLC	209,653	-93,510
0.25990 %	Parametric Portfolio Associates LLC	204,909	-10,102
0.25721 %	Hightower Advisors, LLC	202,788	-19,739
0.24869 %	Jupiter Asset Management Ltd.	196,064	0
0.24605 %	BNY Mellon Asset Management	193,989	8,822
0.22643 %	Barnes (Stephen H.)	178,516	810
0.22360 %	BlackRock Investment Management, LLC	176,290	858
0.21876 %	Cavanaugh (Robert)	172,467	827
0.19838 %	Goldman Sachs Asset Management International	156,402	8,796
0.19663 %	Equitable Trust Company	155,020	0
0.18687 %	Deutsche Asset Management Americas	147,327	-12,000
0.17902 %	Stifel, Nicolaus & Company, Incorporated	141,142	13,939
0.17211 %	Northern Trust Global Investments	135,695	-13,066
0.17149 %	Schweizerische Nationalbank	135,200	-14,400
0.16352 %	Barclays Bank PLC	128,916	91,286
0.15375 %	Group One Trading, L.P.	121,219	68,478
0.15099 %	Mellon Investments Corporation	119,041	77,640
0.14708 %	Dimensional Fund Advisors, Ltd.	115,954	1,091
0.14346 %	Jennison Associates LLC	113,100	16,000
0.13640 %	Lazard Asset Management, L.L.C.	107,537	-7,014
0.13469 %	UBS Financial Services, Inc.	106,188	-57,463
0.13013 %	CIBC Private Wealth Management	102,598	0
0.12924 %	Ruth Asset Management AB	101,892	25,947
0.12716 %	Nordea Funds Oy	100,251	-6,513
0.12668 %	Rhumbline Advisers Ltd. Partnership	99,871	-2,911
0.11751 %	Simplex Trading, LLC	92,648	45,653
0.11669 %	PGIM Fixed Income	92,000	-3,200
0.11333 %	BMO Capital Markets (US)	89,353	-398,248
0.10952 %	Credit Suisse Funds AG	86,343	3,640
0.10931 %	ClariVest Asset Management LLC	86,177	-75
0.10839 %	BlackRock Advisors (UK) Limited	85,451	2,023
0.10600 %	Susquehanna International Group, LLP	83,568	29,970
0.10532 %	Two Sigma Investments, LP	83,037	-60,000
0.10399 %	Cresset Asset Management, LLC	81,983	1,064
0.09952 %	Bridgewater Associates, LP	78,463	-10,150
0.09720 %	Legal & General Investment Management Ltd.	76,631	-171
0.09706 %	Brinker Capital Investments, LLC	76,519	-7,032
0.09669 %	U.S. Bancorp Asset Management, Inc.	76,234	466
0.09525 %	AllianceBernstein L.P.	75,092	0
0.09318 %	Invesco Capital Management LLC	73,464	816
0.09164 %	California State Teachers Retirement System	72,247	-2,880
0.08234 %	BlackRock Asset Management Ireland Limited	64,913	-2,454
0.08004 %	Corient Private Wealth LLC	63,102	50
0.07827 %	Goldman Sachs Asset Management, L.P.	61,709	-226,482
0.07566 %	Newton Investment Management North America, LLC	59,651	-14,635
0.07287 %	Miracle Mile Advisors, LLC	57,447	20
0.07148 %	Citadel Advisors LLC	56,358	-86,954
0.07122 %	Los Angeles Capital Management LLC	56,149	39,330
0.06865 %	Knights of Columbus	54,124	27,062
0.06400 %	Mirae Asset Global Investments (USA) LLC	50,461	420
0.06369 %	Camden Capital, LLC	50,214	50,214
0.06083 %	William Blair & Company, L.L.C. (Research)	47,956	-58,939
0.06009 %	UBS Asset Management (Switzerland)	47,374	0
0.05843 %	Tower Research Capital LLC	46,065	26,920
0.05704 %	Aperio Group, LLC	44,967	-7,112
0.05602 %	Neff (Thomas J)	44,169	1,207
0.05588 %	Cerity Partners LLC	44,057	0
0.05525 %	AJ Wealth Strategies, LLC	43,557	0
0.05505 %	Waypoint Wealth Partners Inc.	43,400	0
0.05502 %	Goldman Sachs & Company, Inc.	43,380	-100,312
0.05390 %	BlackRock Investment Management (UK) Ltd.	42,493	-13,001

이름	관계	이주간 상관관계	원월 상관관계	삼개월 상관계수	여섯달 상관관계	일년간 상관관계	이년 상관관계
American Airlines Group	공급업체고객	0,53	0,48	-0,10	0,18	0,78	-
Lowe's	공급업체고객	0,41	0,47	0,71	0,89	-0,30	-
Change Healthcare	공급업체고객	0,30	0,39	-0,48	-0,66	-	-
Premier A	공급업체고객	0,23	0,16	-0,46	0,58	-0,04	-
Amazon.com	공급업체고객	0,08	0,18	0,42	0,65	0,59	-
Comcast A	공급업체고객	-0,01	0,22	0,44	0,71	0,92	-
Alphabet A	공급업체고객	-0,03	0,29	0,64	0,76	-0,13	-
Limeade CDI	공급업체고객	-0,18	0,01	0,19	0,75	0,92	-

What values and corporate philosophy does Accolade represent?

Accolade Inc represents values of innovation, collaboration, and customer-centricity. With a strong corporate philosophy focused on improving healthcare experiences, Accolade Inc strives to empower individuals and families to navigate their health and benefits in a personalized and effective manner. By combining technology and human expertise, the company aims to deliver comprehensive support, enhance outcomes, and reduce healthcare costs. Accolade Inc's commitment to delivering exceptional service and its emphasis on providing personalized health advocacy aligns with its mission to empower individuals and transform the healthcare industry.

In which countries and regions is Accolade primarily present?

Accolade Inc is primarily present in the United States of America.

What significant milestones has the company Accolade achieved?

Accolade Inc has achieved several significant milestones since its inception. The company successfully completed its initial public offering (IPO) in July 2020, marking a major achievement in its growth trajectory. In recent years, Accolade Inc has formed strategic partnerships with various renowned healthcare organizations, enhancing its market presence and enabling provision of personalized healthcare solutions. With its innovative technology and dedicated team, Accolade Inc has rapidly expanded its customer base, serving millions of individuals across the United States. The company's revolutionary approach to healthcare management has garnered recognition, including being named a Fast Company's Most Innovative Company in 2021. Accolade Inc continues to drive innovation in the healthcare industry, revolutionizing the way individuals access and navigate their healthcare choices.

What is the history and background of the company Accolade?

Accolade Inc, founded in 2007, is a leading technology-enabled healthcare company headquartered in Seattle, Washington. The company provides personalized healthcare and benefits solutions to its clients, including employers, health plans, and health systems. With a mission to improve the healthcare experience for individuals and their families, Accolade Inc combines cutting-edge technology and human expertise to deliver personalized health and benefits services. Over the years, Accolade Inc has established itself as a trusted partner in the industry, leveraging their deep domain knowledge and innovative solutions to support individuals in navigating the complex healthcare landscape efficiently and effectively. This commitment to customer-centric healthcare has propelled Accolade Inc to become a recognized leader in the industry.

Who are the main competitors of Accolade in the market?

Accolade Inc faces competition from various companies in the market. Some of its main competitors include Teladoc Health, Livongo Health, and Health Catalyst. These companies also operate in the healthcare technology sector, providing similar services and solutions. However, Accolade Inc distinguishes itself through its unique combination of personal health support and advanced technology platforms, offering a comprehensive approach to healthcare management and improving patient outcomes.

In which industries is Accolade primarily active?

Accolade Inc is primarily active in the healthcare and technology industries.

What is the business model of Accolade?

Accolade Inc operates as a healthcare technology and services company. The company's business model is based on providing personalized health and benefits solutions to individuals and their families. Accolade's services include healthcare navigation, behavioral health support, benefits advisory, and chronic condition management. By combining technology and human touch, Accolade aims to simplify and improve access to healthcare for its clients. Through their platform, Accolade Inc aims to empower individuals in making informed healthcare decisions, managing their health conditions, and optimizing their overall well-being. Accolade Inc strives to enhance healthcare outcomes and reduce costs for both individuals and employers.

Accolade 2024의 P/E 비율은 얼마입니까?

Accolade의 P/E 비율은 -3.02입니다.

Accolade 2024의 KUV는 얼마입니까?

Accolade의 P/S 비율은 0.73입니다.

Accolade의 AlleAktien 품질 점수는 얼마인가요?

Accolade에 대한 AlleAktien 품질 점수는 4/10입니다.

Accolade 2024의 매출은 얼마인가요?

Accolade 매출은 414.29 백만 USD입니다.

Accolade 2024의 이익은 얼마인가요?

Accolade 이익은 -99.81 백만 USD입니다.

Accolade은 무엇을 하나요?

Accolade is a technology and healthcare company that develops innovative solutions for improving healthcare.

Accolade 배당금은 얼마입니까?

Accolade은(는) 연간 번의 배당을 통해 0 USD의 배당금을 지급합니다.

Accolade이 얼마나 자주 배당을 지급하나요?

Accolade의 현재 배당금은 계산할 수 없거나, 회사가 배당금을 지급하지 않습니다.

Accolade ISIN이 무엇입니까?

Accolade의 ISIN은 US00437E1029입니다.

Accolade WKN은 무엇인가요?

Accolade의 WKN은 A2P7Z2입니다.

Accolade 티커는 무엇인가요?

Accolade의 티커는 ACCD입니다.

Accolade이 얼마만큼의 배당금을 지급합니까?

지난 12개월 동안 Accolade은(는) 의 배당금을 지급했습니다. 이는 약 의 배당 수익률에 해당합니다. 향후 12개월 동안 Accolade은(는) 0 USD의 배당금을 지급할 것으로 예상됩니다.

Accolade의 배당 수익률은 얼마입니까?

Accolade의 현재 배당 수익률은 입니다.

Accolade의 배당금은 언제 지급되나요?

Accolade은 분기별로 배당금을 지급합니다. 이는 월에 배당됩니다.

Accolade의 배당금은 얼마나 안전한가요?

Accolade은(는) 지난 0년 동안 매년 배당금을 지급했습니다.

Accolade의 배당금은 얼마입니까?

향후 12개월 동안 0 USD의 배당금이 예상됩니다. 이는 배당수익률 0 %에 해당합니다.

Accolade이(가) 속해 있는 섹터는 어디인가요?

Accolade은 '건강' 섹터에 속합니다.

Wann musste ich die Aktien von Accolade kaufen, um die vorherige Dividende zu erhalten?

Accolade의 마지막 배당금을 0 USD만큼 받기 위해선 의 Ex-Tag 전에 주식을 보유하고 있어야 했습니다.

Accolade의 마지막 배당금 지급일은 언제였습니까?

마지막 배당금 지급일은 입니다.

Accolade의 2023년도 배당금은 얼마였습니까?

2023년에 Accolade는 0 USD를 배당금으로 지급했습니다.

Accolade는 어떤 화폐로 배당금을 지급하나요?

Accolade의 배당금은 USD에 지급됩니다.

Scope 1 - 직접 방출	—
스코프 2 - 구매한 에너지로부터의 간접적인 배출	—
Scope 3 - 가치 창출 체인 내의 간접 배출	—
총 CO₂ 배출량	—
CO₂ 감소 전략	✅
석탄 에너지	❌
원자력	❌
동물 실험	❌
펠츠 & 레더	—
살충제	—
팜 오일	—
담배	❌
유전자 변형 생물체	❌
기후 개념	—
지속 가능한 임업	—
재활용 규정	❌
환경 친화적인 포장	❌
위험물질	❌
연료 소비량과 효율성	❌
물 사용량 및 효율성	❌

여성 직원 비율	70
관리 직위에서의 여성 비율	—
아시아 직원 비율	7.1
아시아 경영진 비율	9.9
히스패닉/라티노 직원 비율	10.1
히스패닉/라티노 관리 부문 지분	7.1
흑인 직원 비율	20.8
블랙 매니지먼트 지분	10.3
흰색 종업원의 비율	58.1
화이트 매니지먼트 지분	69.9
성인 콘텐츠	❌
알코올	❌
무기	—
총기	❌
도박	❌
군사 계약	❌
인권 개념	❌
개인정보 보호 정책	—
작업 및 건강 보호	❌
카톨릭	✅

환경 보고	❌
이해관계자 참여	❌
콜백 정책	❌
카르텔법	❌

증권거래소	Accolade 티커
뒤셀도르프	4NE1.DU
프랑크푸르트	4NE1.F
뮌헨	4NE1.MU
NASDAQ	ACCD

Accolade 티커	Accolade FIGI
ACCD:US	BBG00S2L1Z00
ACCD:UA	BBG00S2L1Z19
ACCD:UC	BBG00S2L1Z28
ACCD:UN	BBG00S2L1Z46
ACCD:UP	BBG00S2L1Z55
ACCD:UB	BBG00S2L1Z73
ACCD:UM	BBG00S2L1Z91
ACCD:UX	BBG00S2L1ZB8
ACCD:UD	BBG00S2L1ZH2
ACCD:UW	BBG00S2L1ZK8
ACCD:UF	BBG00S2L1ZL7
ACCD:VY	BBG00S2L1ZM6
ACCD:VJ	BBG00S2L1ZN5
ACCD:VK	BBG00S2L1ZP3
ACCD:VF	BBG00S2L1ZQ2
ACCD:VG	BBG00X1PJY05
ACCD:VP	BBG00X1SZBD7
4NE1:GR	BBG00ZSK4ZQ7
4NE1:GF	BBG00ZSK4ZR6
4NE1:GD	BBG00ZSK4ZS5
4NE1:GS	BBG00ZSK4ZV1
4NE1:GM	BBG00ZSK4ZW0
4NE1:GB	BBG00ZSK4ZX9
4NE1:TH	BBG00ZSLR336
4NE1:GZ	BBG00ZTZNTY7
ACCDEUR:XH	BBG00ZV1B743
ACCDEUR:XF	BBG00ZV1B761
ACCDEUR:XE	BBG00ZV1B789
ACCDEUR:XL	BBG00ZV1B7B5
ACCDEUR:XG	BBG00ZV1B7C4
ACCDEUR:XO	BBG00ZV1B7D3
ACCDEUR:XA	BBG00ZV1B7J7
ACCDEUR:XT	BBG00ZV1B7L4
ACCDEUR:XW	BBG00ZV1B7M3
ACCDEUR:XU	BBG00ZV1B7N2
ACCDEUR:XV	BBG00ZV1B7Q9
ACCDEUR:XM	BBG00ZV1B7R8
ACCDEUR:EU	BBG00ZV1B7Z9
4NE1:QT	BBG00ZWTDCP5
ACCDUSD:XH	BBG00ZXRH702
ACCDUSD:XF	BBG00ZXRH720
ACCDUSD:XE	BBG00ZXRH748
ACCDUSD:XL	BBG00ZXRH766
ACCDUSD:XG	BBG00ZXRH775
ACCDUSD:XO	BBG00ZXRH784
ACCDUSD:XA	BBG00ZXRH7D8
ACCDUSD:XT	BBG00ZXRH7G5
ACCDUSD:XW	BBG00ZXRH7H4
ACCDUSD:XU	BBG00ZXRH7J2
ACCDUSD:XV	BBG00ZXRH7L9
ACCDUSD:XM	BBG00ZXRH7M8
ACCDUSD:EU	BBG00ZXRH7V8
ACCDGBP:XH	BBG00ZXRM6G1
ACCDGBP:XF	BBG00ZXRM6J8
ACCDGBP:XE	BBG00ZXRM6L5
ACCDGBP:XL	BBG00ZXRM6N3
ACCDGBP:XG	BBG00ZXRM6P1
ACCDGBP:XO	BBG00ZXRM6Q0
ACCDGBP:XA	BBG00ZXRM6V4
ACCDGBP:XT	BBG00ZXRM6X2
ACCDGBP:XW	BBG00ZXRM6Y1
ACCDGBP:XU	BBG00ZXRM6Z0
ACCDGBP:XV	BBG00ZXRM715
ACCDGBP:XM	BBG00ZXRM724
ACCDGBP:EU	BBG00ZXRM797
4NE1:LA	BBG018HBLMV2
4NE1:LU	BBG018J484N0

한 눈에 저평가된 주식을 인식하세요 fair value · 20 million securities worldwide · 50 year history · 10 year estimates · leading business news

Accolade 주식 주식과 주식 분석 Accolade ariva, Accolade onvista, Accolade finanzen.net, Accolade aktienfinder, Accolade marketscreener, Accolade marketwatch, Accolade bloomberg, Accolade handelsblatt, Accolade wiwo, Accolade forum

가격

가격

티커ACCD

ISINUS00437E1029

WKNA2P7Z2

Accolade 주식 가격

가격

개요

인트라데이 기능

총 수익률 및 상대 가격 변동

해석 및 투자

Accolade 주가 이력

Accolade 주식 매출, EBIT, 이익 US00437E1029 · A2P7Z2

매출, 이익 & EBIT

매출, EBIT, 소득 이해하기

연간 분석 및 비교

투자 기대치 활용

투자 통찰력

Accolade 매출, 이익 및 EBIT 역사

Accolade 주식 지표

손익계산서

매출 성장

총 이익률

EBIT와 EBIT 마진

수입과 성장

발행 주식

연간 비교의 해석

기대치와 예측

재무 상태표

재무 상태표 이해

자산

부채

자본

년대비 분석

데이터 해석

Accolade 주식 마진 US00437E1029 · A2P7Z2

마진

매출 총이익률 이해

EBIT 마진 분석

매출 마진에 대한 인사이트

기대치 해석

비교 분석

Accolade 마진 역사

Accolade 주식 매출, EBIT, 주당 순이익 US00437E1029 · A2P7Z2

매출, EBIT 및 주당 이익

주당 매출

주당 EBIT

주당 수익

예상 값

Accolade 매출, 이익 및 EBIT 주당 역사

Accolade 주식 및 주식 분석

Accolade Fair Value에 따른 평가

Fair Value

Fair Value 이해하기

수익 기반 Fair Value

매출 기반 Fair Value

배당 기반 Fair Value

기대치와 예측

비교 분석

Accolade 역사적인 P/E, EBIT 및 P/S에 따른 평가

Accolade 주식 수량 US00437E1029 · A2P7Z2

매출, EBIT 및 주당 이익

주당 매출

주당 EBIT

주당 수익

예상 값

Accolade 수익 예상

Accolade 수익 놀라움

Eulerpool ESG Scorecard© Accolade 주식을 위해

Eulerpool World ESG Rating (EESG©)

38/ 100

🌱 Environment

👫 Social

🏛️ Governance

환경

소셜 (사회적)

지배구조 (기업 경영)

Accolade 주식 주주 구조

한 눈에 저평가된 주식을 인식하세요
fair value · 20 million securities worldwide · 50 year history · 10 year estimates · leading business news

Accolade 주식
주식과 주식 분석 Accolade ariva, Accolade onvista, Accolade finanzen.net, Accolade aktienfinder, Accolade marketscreener, Accolade marketwatch, Accolade bloomberg, Accolade handelsblatt, Accolade wiwo, Accolade forum

티커
ACCD

ISIN
US00437E1029

WKN
A2P7Z2